Treatment of Thoracic Syrinx
Surgical decompression targeting the underlying cause is the definitive treatment for symptomatic thoracic syringomyelia, with posterior fossa decompression for Chiari-associated cases and spinal decompression or shunting procedures for other etiologies. 1
Initial Diagnostic Workup
- Obtain MRI of the entire spine (not just the symptomatic region) using T1-weighted, T2-weighted, FLAIR, and post-contrast sequences to determine the full extent of the syrinx and identify the underlying cause 1
- Include brain imaging to evaluate for Chiari malformation, which is present in 25-50% of syringomyelia cases and represents the most common etiology 1
- Look specifically for spinal arachnoiditis, arachnoid webs, epidural lipomatosis, or other compressive lesions that may be causing CSF flow obstruction 2, 3, 4
Surgical Management Based on Etiology
Chiari Malformation-Associated Syringomyelia
Posterior fossa decompression with or without duraplasty is the first-line surgical treatment for Chiari-associated thoracic syrinx 1
- Both techniques (with and without duraplasty) demonstrate benefit for symptom relief and syrinx reduction 1
- Consider cerebellar tonsil reduction during the decompression procedure to enhance syrinx improvement (Grade C recommendation) 1
- This approach addresses the underlying CSF flow obstruction at the foramen magnum 5
Spinal Arachnoiditis or Arachnoid Web-Associated Syrinx
- Perform laminectomy at the level of the web or adhesions with surgical excision of the arachnoid web to decompress the subarachnoid space and restore normal CSF flow 2
- The syrinx typically originates at the thoracic level where severe subarachnoid adhesion is present 3
- Surgical resection can be curative with possible complete remission of symptoms and normalization of spinal anatomy 2
Shunting Procedures
When primary decompression is not feasible or has failed:
- Syringoperitoneal shunt is the most commonly used shunting procedure 3
- Syringosubarachnoid shunt can be performed, particularly for short thoracic syringes using minimally invasive keyhole laminectomy 3, 6
- Shunting procedures are effective in approximately 60% of patients with neurologic improvement and decreased syrinx size 3
- Be aware that repeat shunting operations may be required in up to 53% of patients (8 of 15 in one series) within 2 months to 12 years after initial surgery 3
Post-Operative Management and Monitoring
Allow 6-12 months for syrinx reduction after initial surgery before considering additional intervention (Grade B recommendation) 1, 7
- Obtain follow-up MRI at 6-12 months post-operatively to assess syrinx size and CSF flow 1, 7
- Understand that symptom resolution and syrinx resolution do not correlate directly—clinical improvement can occur without complete radiographic resolution, and vice versa 7
- Monitor for new or worsening symptoms during this observation period 7
Indications for Reoperation
Consider additional neurosurgical intervention if:
- No radiographic improvement of the syrinx after 6-12 months of observation 1, 7
- Progressive clinical deterioration despite initial surgery 1
- Development of new neurologic symptoms suggesting syrinx expansion 2
Critical Pitfalls to Avoid
- Do not image only the symptomatic spinal region—thoracic syringes can extend rostrally to C1 or caudally beyond the initially suspected area 1, 2
- Do not rush to reoperation before allowing 6-12 months for syrinx improvement, as many resolve during this timeframe 1, 7
- Do not assume stability based on lack of symptoms alone—syringes can enlarge asymptomatically, and prolonged severe stenosis can cause irreversible spinal cord damage 8
- Do not delay evaluation of new or worsening symptoms, as these may indicate recurrence or complications requiring intervention 8
Expected Outcomes
- Neurologic improvement occurs in approximately 60% of patients with appropriate surgical intervention 3
- Complete resolution of symptoms is possible, particularly with arachnoid web excision 2
- Syringomyelia is a progressive disease that can expand rostrally with worsening symptoms if left untreated 2
- Some patients may experience gradual deterioration (approximately 33% in one series) despite surgical treatment 3